HIV reservoirs as obstacles and opportunities for an HIV cure (Q41216521)

28 September 2017

title

HIV reservoirs as obstacles and opportunities for an HIV cure (English)

1 reference

28 September 2017

0 references

3

Anthony S Fauci

1 reference

28 September 2017

1

Tae-Wook Chun

1 reference

28 September 2017

2

Susan Moir

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

28 September 2017

1 reference

28 September 2017

volume

16

1 reference

28 September 2017

issue

6

1 reference

28 September 2017

page(s)

584-589

1 reference

Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies

28 September 2017

cites work

1 reference

Life expectancy living with HIV: recent estimates and future implications

21 January 2018

1 reference

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

21 January 2018

1 reference

Towards an HIV cure: a global scientific strategy

21 January 2018

1 reference

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

21 January 2018

1 reference

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

21 January 2018

1 reference

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

21 January 2018

1 reference

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir

21 January 2018

1 reference

Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues

21 January 2018

1 reference

Overcoming pharmacologic sanctuaries

21 January 2018

1 reference

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

21 January 2018

1 reference

HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

21 January 2018

1 reference

HIV-1 integration landscape during latent and active infection

21 January 2018

1 reference

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

21 January 2018

1 reference

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

21 January 2018

1 reference

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

21 January 2018

1 reference

Histone deacetylase inhibitors and HIV latency

21 January 2018

1 reference

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

21 January 2018

1 reference

Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study.

21 January 2018

1 reference

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

21 January 2018

1 reference

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

21 January 2018

1 reference

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

21 January 2018

1 reference

Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy

21 January 2018

1 reference

New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.

21 January 2018

1 reference

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation

21 January 2018

1 reference

Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations

21 January 2018

1 reference

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

21 January 2018

1 reference

Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient

21 January 2018

1 reference

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation

21 January 2018

1 reference

Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases

21 January 2018

1 reference

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

21 January 2018

1 reference

Targeted gene disruption to cure HIV

21 January 2018

1 reference

Unravelling the mechanisms of durable control of HIV-1.

21 January 2018

1 reference

Effect of antiretroviral therapy on HIV reservoirs in elite controllers

21 January 2018

1 reference

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy

21 January 2018

1 reference

HIV-1 continues to replicate and evolve in patients with natural control of HIV infection

21 January 2018

1 reference

Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV.

21 January 2018

1 reference

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

21 January 2018

1 reference

Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

21 January 2018

1 reference

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

21 January 2018

1 reference

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

21 January 2018

1 reference

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection

21 January 2018

1 reference

Absence of detectable HIV-1 viremia after treatment cessation in an infant

21 January 2018

1 reference

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

21 January 2018

1 reference

Viremic relapse after HIV-1 remission in a perinatally infected child

21 January 2018

1 reference

HIV-1 vaccines and adaptive trial designs

21 January 2018

1 reference

A Blueprint for HIV Vaccine Discovery

21 January 2018

1 reference

Immune interventions in HIV infection

21 January 2018

1 reference

Prospects for an HIV vaccine: leading B cells down the right path

21 January 2018

1 reference

Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir

21 January 2018

1 reference

Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice

21 January 2018

1 reference

Immunologic strategies for HIV-1 remission and eradication

21 January 2018

1 reference

Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies

21 January 2018

1 reference

Re-emergence of HIV after stopping therapy

21 January 2018

1 reference

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

21 January 2018

1 reference

12 December 2020

More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutation

1 reference

12 December 2020

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

1 reference

12 December 2020

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

1 reference

12 December 2020

More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutation

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NI.3152

1 reference

28 September 2017

1 reference